nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—SLC15A2—choroid plexus—malignant glioma	0.0378	0.139	CbGeAlD
Glyburide—KCNJ5—brainstem—malignant glioma	0.0166	0.0609	CbGeAlD
Glyburide—ABCA1—blood vessel—malignant glioma	0.0156	0.0572	CbGeAlD
Glyburide—Myelosuppression—Carmustine—malignant glioma	0.0115	0.0493	CcSEcCtD
Glyburide—Myelosuppression—Temozolomide—malignant glioma	0.0111	0.0476	CcSEcCtD
Glyburide—KCNJ5—central nervous system—malignant glioma	0.00839	0.0307	CbGeAlD
Glyburide—Encephalopathy—Carmustine—malignant glioma	0.00837	0.036	CcSEcCtD
Glyburide—KCNJ5—cerebellum—malignant glioma	0.0082	0.03	CbGeAlD
Glyburide—CPT1A—telencephalon—malignant glioma	0.00814	0.0298	CbGeAlD
Glyburide—KCNJ1—telencephalon—malignant glioma	0.00797	0.0292	CbGeAlD
Glyburide—Digestion impaired—Temozolomide—malignant glioma	0.00776	0.0334	CcSEcCtD
Glyburide—ABCA1—telencephalon—malignant glioma	0.00758	0.0278	CbGeAlD
Glyburide—Cholestasis—Temozolomide—malignant glioma	0.00683	0.0294	CcSEcCtD
Glyburide—Coagulopathy—Temozolomide—malignant glioma	0.00667	0.0287	CcSEcCtD
Glyburide—KCNJ5—brain—malignant glioma	0.00666	0.0244	CbGeAlD
Glyburide—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00571	0.0246	CcSEcCtD
Glyburide—ABCA1—spinal cord—malignant glioma	0.00531	0.0195	CbGeAlD
Glyburide—Gliclazide—VEGFA—malignant glioma	0.0052	0.24	CrCbGaD
Glyburide—ABCC9—brain—malignant glioma	0.00505	0.0185	CbGeAlD
Glyburide—ABCC8—brainstem—malignant glioma	0.00502	0.0184	CbGeAlD
Glyburide—Aplastic anaemia—Temozolomide—malignant glioma	0.00487	0.021	CcSEcCtD
Glyburide—KCNJ1—central nervous system—malignant glioma	0.00453	0.0166	CbGeAlD
Glyburide—CPT1A—cerebellum—malignant glioma	0.00452	0.0166	CbGeAlD
Glyburide—ABCC8—telencephalon—malignant glioma	0.00445	0.0163	CbGeAlD
Glyburide—ABCA1—central nervous system—malignant glioma	0.00431	0.0158	CbGeAlD
Glyburide—Sulpiride—BCHE—malignant glioma	0.00422	0.195	CrCbGaD
Glyburide—ABCA1—cerebellum—malignant glioma	0.00421	0.0154	CbGeAlD
Glyburide—Vascular purpura—Temozolomide—malignant glioma	0.00421	0.0181	CcSEcCtD
Glyburide—Deafness—Temozolomide—malignant glioma	0.00421	0.0181	CcSEcCtD
Glyburide—Hepatic failure—Temozolomide—malignant glioma	0.00419	0.018	CcSEcCtD
Glyburide—Glipizide—PPARG—malignant glioma	0.00399	0.185	CrCbGaD
Glyburide—Hyponatraemia—Carmustine—malignant glioma	0.00391	0.0168	CcSEcCtD
Glyburide—Purpura—Temozolomide—malignant glioma	0.00391	0.0168	CcSEcCtD
Glyburide—Diplopia—Carmustine—malignant glioma	0.0039	0.0168	CcSEcCtD
Glyburide—Diplopia—Temozolomide—malignant glioma	0.00377	0.0162	CcSEcCtD
Glyburide—CPT1A—brain—malignant glioma	0.00367	0.0135	CbGeAlD
Glyburide—KCNJ1—brain—malignant glioma	0.0036	0.0132	CbGeAlD
Glyburide—ABCC8—medulla oblongata—malignant glioma	0.0035	0.0128	CbGeAlD
Glyburide—SLCO2B1—telencephalon—malignant glioma	0.00349	0.0128	CbGeAlD
Glyburide—ABCA1—brain—malignant glioma	0.00342	0.0125	CbGeAlD
Glyburide—Abdominal distension—Temozolomide—malignant glioma	0.00328	0.0141	CcSEcCtD
Glyburide—CFTR—brain—malignant glioma	0.00323	0.0118	CbGeAlD
Glyburide—SLCO1A2—telencephalon—malignant glioma	0.00321	0.0117	CbGeAlD
Glyburide—Pancytopenia—Carmustine—malignant glioma	0.0032	0.0138	CcSEcCtD
Glyburide—ABCC8—midbrain—malignant glioma	0.0032	0.0117	CbGeAlD
Glyburide—Zafirlukast—PTGS1—malignant glioma	0.00319	0.147	CrCbGaD
Glyburide—Sweating increased—Temozolomide—malignant glioma	0.00317	0.0136	CcSEcCtD
Glyburide—ABCC8—spinal cord—malignant glioma	0.00312	0.0114	CbGeAlD
Glyburide—Pancytopenia—Temozolomide—malignant glioma	0.00309	0.0133	CcSEcCtD
Glyburide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00297	0.0128	CcSEcCtD
Glyburide—Bezafibrate—PPARG—malignant glioma	0.00291	0.135	CrCbGaD
Glyburide—SLC15A2—retina—malignant glioma	0.00289	0.0106	CbGeAlD
Glyburide—KCNJ11—central nervous system—malignant glioma	0.00275	0.0101	CbGeAlD
Glyburide—SLCO2B1—medulla oblongata—malignant glioma	0.00274	0.01	CbGeAlD
Glyburide—KCNJ11—cerebellum—malignant glioma	0.00269	0.00984	CbGeAlD
Glyburide—SLC15A2—telencephalon—malignant glioma	0.00266	0.00975	CbGeAlD
Glyburide—ABCC1—telencephalon—malignant glioma	0.00263	0.00964	CbGeAlD
Glyburide—Hepatitis—Temozolomide—malignant glioma	0.00261	0.0112	CcSEcCtD
Glyburide—Visual impairment—Carmustine—malignant glioma	0.0026	0.0112	CcSEcCtD
Glyburide—ABCC8—central nervous system—malignant glioma	0.00253	0.00927	CbGeAlD
Glyburide—Eye disorder—Carmustine—malignant glioma	0.00252	0.0108	CcSEcCtD
Glyburide—SLCO1A2—medulla oblongata—malignant glioma	0.00252	0.00923	CbGeAlD
Glyburide—Visual impairment—Temozolomide—malignant glioma	0.00251	0.0108	CcSEcCtD
Glyburide—ABCC8—cerebellum—malignant glioma	0.00247	0.00906	CbGeAlD
Glyburide—SLCO2B1—spinal cord—malignant glioma	0.00244	0.00894	CbGeAlD
Glyburide—Eye disorder—Temozolomide—malignant glioma	0.00244	0.0105	CcSEcCtD
Glyburide—SLC22A7—brain—malignant glioma	0.00239	0.00876	CbGeAlD
Glyburide—Alopecia—Carmustine—malignant glioma	0.00238	0.0103	CcSEcCtD
Glyburide—Erythema—Carmustine—malignant glioma	0.00235	0.0101	CcSEcCtD
Glyburide—Malnutrition—Carmustine—malignant glioma	0.00235	0.0101	CcSEcCtD
Glyburide—SLC22A6—brain—malignant glioma	0.00231	0.00845	CbGeAlD
Glyburide—SLCO1A2—midbrain—malignant glioma	0.0023	0.00844	CbGeAlD
Glyburide—Alopecia—Temozolomide—malignant glioma	0.0023	0.00991	CcSEcCtD
Glyburide—Malnutrition—Temozolomide—malignant glioma	0.00227	0.00976	CcSEcCtD
Glyburide—Erythema—Temozolomide—malignant glioma	0.00227	0.00976	CcSEcCtD
Glyburide—SLCO1A2—spinal cord—malignant glioma	0.00225	0.00823	CbGeAlD
Glyburide—ABCB1—blood vessel—malignant glioma	0.00221	0.00811	CbGeAlD
Glyburide—Vision blurred—Carmustine—malignant glioma	0.00221	0.00952	CcSEcCtD
Glyburide—Tremor—Carmustine—malignant glioma	0.0022	0.00946	CcSEcCtD
Glyburide—KCNJ11—brain—malignant glioma	0.00218	0.00799	CbGeAlD
Glyburide—ABCG2—telencephalon—malignant glioma	0.00218	0.00798	CbGeAlD
Glyburide—Anaemia—Carmustine—malignant glioma	0.00217	0.00933	CcSEcCtD
Glyburide—Vision blurred—Temozolomide—malignant glioma	0.00214	0.0092	CcSEcCtD
Glyburide—Chlorpropamide—PTGS1—malignant glioma	0.00213	0.0985	CrCbGaD
Glyburide—Tremor—Temozolomide—malignant glioma	0.00213	0.00914	CcSEcCtD
Glyburide—ABCC3—central nervous system—malignant glioma	0.00213	0.00778	CbGeAlD
Glyburide—Leukopenia—Carmustine—malignant glioma	0.0021	0.00904	CcSEcCtD
Glyburide—Anaemia—Temozolomide—malignant glioma	0.0021	0.00902	CcSEcCtD
Glyburide—SLC15A2—medulla oblongata—malignant glioma	0.00209	0.00766	CbGeAlD
Glyburide—Angioedema—Temozolomide—malignant glioma	0.00207	0.00892	CcSEcCtD
Glyburide—Convulsion—Carmustine—malignant glioma	0.00203	0.00875	CcSEcCtD
Glyburide—Leukopenia—Temozolomide—malignant glioma	0.00203	0.00874	CcSEcCtD
Glyburide—ABCC8—brain—malignant glioma	0.00201	0.00736	CbGeAlD
Glyburide—Myalgia—Carmustine—malignant glioma	0.002	0.0086	CcSEcCtD
Glyburide—SLCO2B1—central nervous system—malignant glioma	0.00198	0.00726	CbGeAlD
Glyburide—Convulsion—Temozolomide—malignant glioma	0.00197	0.00846	CcSEcCtD
Glyburide—SLCO2B1—cerebellum—malignant glioma	0.00194	0.00709	CbGeAlD
Glyburide—Confusional state—Carmustine—malignant glioma	0.00193	0.00831	CcSEcCtD
Glyburide—Myalgia—Temozolomide—malignant glioma	0.00193	0.00831	CcSEcCtD
Glyburide—Arthralgia—Temozolomide—malignant glioma	0.00193	0.00831	CcSEcCtD
Glyburide—Oedema—Carmustine—malignant glioma	0.00192	0.00824	CcSEcCtD
Glyburide—SLC15A2—midbrain—malignant glioma	0.00191	0.007	CbGeAlD
Glyburide—Thrombocytopenia—Carmustine—malignant glioma	0.00188	0.00807	CcSEcCtD
Glyburide—Confusional state—Temozolomide—malignant glioma	0.00187	0.00803	CcSEcCtD
Glyburide—SLC15A2—spinal cord—malignant glioma	0.00186	0.00683	CbGeAlD
Glyburide—Oedema—Temozolomide—malignant glioma	0.00185	0.00797	CcSEcCtD
Glyburide—Anorexia—Carmustine—malignant glioma	0.00183	0.00786	CcSEcCtD
Glyburide—SLCO1A2—central nervous system—malignant glioma	0.00182	0.00668	CbGeAlD
Glyburide—Nervous system disorder—Temozolomide—malignant glioma	0.00182	0.00781	CcSEcCtD
Glyburide—Thrombocytopenia—Temozolomide—malignant glioma	0.00181	0.0078	CcSEcCtD
Glyburide—Hypotension—Carmustine—malignant glioma	0.00179	0.0077	CcSEcCtD
Glyburide—Hyperhidrosis—Temozolomide—malignant glioma	0.00179	0.0077	CcSEcCtD
Glyburide—SLCO1A2—cerebellum—malignant glioma	0.00178	0.00653	CbGeAlD
Glyburide—Anorexia—Temozolomide—malignant glioma	0.00177	0.00759	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00175	0.00751	CcSEcCtD
Glyburide—Paraesthesia—Carmustine—malignant glioma	0.00172	0.0074	CcSEcCtD
Glyburide—ABCG2—medulla oblongata—malignant glioma	0.00171	0.00627	CbGeAlD
Glyburide—Dyspnoea—Carmustine—malignant glioma	0.00171	0.00735	CcSEcCtD
Glyburide—ABCC3—brain—malignant glioma	0.00169	0.00618	CbGeAlD
Glyburide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00169	0.00726	CcSEcCtD
Glyburide—Decreased appetite—Carmustine—malignant glioma	0.00167	0.00717	CcSEcCtD
Glyburide—Paraesthesia—Temozolomide—malignant glioma	0.00166	0.00715	CcSEcCtD
Glyburide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00165	0.00712	CcSEcCtD
Glyburide—Dyspnoea—Temozolomide—malignant glioma	0.00165	0.0071	CcSEcCtD
Glyburide—Dyspepsia—Temozolomide—malignant glioma	0.00163	0.00701	CcSEcCtD
Glyburide—Decreased appetite—Temozolomide—malignant glioma	0.00161	0.00692	CcSEcCtD
Glyburide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0016	0.00688	CcSEcCtD
Glyburide—Feeling abnormal—Carmustine—malignant glioma	0.00158	0.00679	CcSEcCtD
Glyburide—SLCO2B1—brain—malignant glioma	0.00157	0.00576	CbGeAlD
Glyburide—Gastrointestinal pain—Carmustine—malignant glioma	0.00157	0.00674	CcSEcCtD
Glyburide—ABCG2—midbrain—malignant glioma	0.00156	0.00573	CbGeAlD
Glyburide—ABCG2—spinal cord—malignant glioma	0.00153	0.00559	CbGeAlD
Glyburide—Feeling abnormal—Temozolomide—malignant glioma	0.00153	0.00656	CcSEcCtD
Glyburide—Abdominal pain—Carmustine—malignant glioma	0.00151	0.00652	CcSEcCtD
Glyburide—Gastrointestinal pain—Temozolomide—malignant glioma	0.00151	0.00651	CcSEcCtD
Glyburide—SLC15A2—central nervous system—malignant glioma	0.00151	0.00554	CbGeAlD
Glyburide—SLC15A2—cerebellum—malignant glioma	0.00148	0.00542	CbGeAlD
Glyburide—Urticaria—Temozolomide—malignant glioma	0.00147	0.00633	CcSEcCtD
Glyburide—Abdominal pain—Temozolomide—malignant glioma	0.00146	0.0063	CcSEcCtD
Glyburide—ABCC1—cerebellum—malignant glioma	0.00146	0.00535	CbGeAlD
Glyburide—SLCO1A2—brain—malignant glioma	0.00145	0.0053	CbGeAlD
Glyburide—ALB—brain—malignant glioma	0.00144	0.00527	CbGeAlD
Glyburide—Hypersensitivity—Carmustine—malignant glioma	0.00141	0.00607	CcSEcCtD
Glyburide—Asthenia—Carmustine—malignant glioma	0.00137	0.00591	CcSEcCtD
Glyburide—Hypersensitivity—Temozolomide—malignant glioma	0.00136	0.00587	CcSEcCtD
Glyburide—Asthenia—Temozolomide—malignant glioma	0.00133	0.00572	CcSEcCtD
Glyburide—ABCB1—embryo—malignant glioma	0.00132	0.00484	CbGeAlD
Glyburide—Diarrhoea—Carmustine—malignant glioma	0.00131	0.00564	CcSEcCtD
Glyburide—Pruritus—Temozolomide—malignant glioma	0.00131	0.00564	CcSEcCtD
Glyburide—Diarrhoea—Temozolomide—malignant glioma	0.00127	0.00545	CcSEcCtD
Glyburide—Vomiting—Carmustine—malignant glioma	0.00122	0.00524	CcSEcCtD
Glyburide—ABCG2—cerebellum—malignant glioma	0.00121	0.00443	CbGeAlD
Glyburide—Rash—Carmustine—malignant glioma	0.00121	0.0052	CcSEcCtD
Glyburide—Dermatitis—Carmustine—malignant glioma	0.00121	0.00519	CcSEcCtD
Glyburide—SLC15A2—brain—malignant glioma	0.0012	0.0044	CbGeAlD
Glyburide—Headache—Carmustine—malignant glioma	0.0012	0.00516	CcSEcCtD
Glyburide—ABCC1—brain—malignant glioma	0.00119	0.00435	CbGeAlD
Glyburide—Vomiting—Temozolomide—malignant glioma	0.00118	0.00506	CcSEcCtD
Glyburide—ABCB1—retina—malignant glioma	0.00117	0.00428	CbGeAlD
Glyburide—Rash—Temozolomide—malignant glioma	0.00117	0.00502	CcSEcCtD
Glyburide—Dermatitis—Temozolomide—malignant glioma	0.00117	0.00502	CcSEcCtD
Glyburide—Headache—Temozolomide—malignant glioma	0.00116	0.00499	CcSEcCtD
Glyburide—Nausea—Carmustine—malignant glioma	0.00114	0.0049	CcSEcCtD
Glyburide—Nausea—Temozolomide—malignant glioma	0.0011	0.00473	CcSEcCtD
Glyburide—ABCB1—telencephalon—malignant glioma	0.00107	0.00393	CbGeAlD
Glyburide—ABCG2—brain—malignant glioma	0.000983	0.0036	CbGeAlD
Glyburide—CYP3A4—central nervous system—malignant glioma	0.000863	0.00316	CbGeAlD
Glyburide—ABCB1—medulla oblongata—malignant glioma	0.000844	0.00309	CbGeAlD
Glyburide—ABCB1—midbrain—malignant glioma	0.000772	0.00283	CbGeAlD
Glyburide—ABCB1—spinal cord—malignant glioma	0.000753	0.00276	CbGeAlD
Glyburide—ABCB1—central nervous system—malignant glioma	0.000611	0.00224	CbGeAlD
Glyburide—ABCB1—cerebellum—malignant glioma	0.000597	0.00219	CbGeAlD
Glyburide—ABCB1—brain—malignant glioma	0.000485	0.00178	CbGeAlD
Glyburide—ABCB11—Metabolism—CAV1—malignant glioma	5.19e-05	0.00011	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—COX8A—malignant glioma	5.18e-05	0.00011	CbGpPWpGaD
Glyburide—ALB—Metabolism—SPHK1—malignant glioma	5.14e-05	0.000109	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CD—malignant glioma	5.1e-05	0.000108	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2B6—malignant glioma	5.09e-05	0.000108	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CAT—malignant glioma	5.06e-05	0.000107	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—IDH2—malignant glioma	5.06e-05	0.000107	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP2C18—malignant glioma	5.04e-05	0.000107	CbGpPWpGaD
Glyburide—ABCC1—Disease—TERT—malignant glioma	5.03e-05	0.000106	CbGpPWpGaD
Glyburide—ABCC1—Disease—HLA-A—malignant glioma	5.03e-05	0.000106	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	5e-05	0.000106	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CAV1—malignant glioma	4.97e-05	0.000105	CbGpPWpGaD
Glyburide—ALB—Hemostasis—F2—malignant glioma	4.97e-05	0.000105	CbGpPWpGaD
Glyburide—ALB—Hemostasis—FN1—malignant glioma	4.97e-05	0.000105	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.96e-05	0.000105	CbGpPWpGaD
Glyburide—ABCC1—Disease—PDGFB—malignant glioma	4.91e-05	0.000104	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.89e-05	0.000103	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGFR1—malignant glioma	4.89e-05	0.000103	CbGpPWpGaD
Glyburide—ABCC1—Disease—HIF1A—malignant glioma	4.81e-05	0.000102	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NCOR1—malignant glioma	4.78e-05	0.000101	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—IDH1—malignant glioma	4.77e-05	0.000101	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.77e-05	0.000101	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.76e-05	0.000101	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CG—malignant glioma	4.75e-05	0.000101	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.75e-05	0.0001	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.75e-05	0.0001	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CG—malignant glioma	4.73e-05	9.99e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EGF—malignant glioma	4.7e-05	9.94e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PTPN11—malignant glioma	4.67e-05	9.88e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—IDH1—malignant glioma	4.66e-05	9.85e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.65e-05	9.84e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CAV1—malignant glioma	4.65e-05	9.84e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.62e-05	9.77e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SPHK1—malignant glioma	4.62e-05	9.77e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CB—malignant glioma	4.58e-05	9.69e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GSTP1—malignant glioma	4.58e-05	9.68e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PPARG—malignant glioma	4.56e-05	9.65e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—malignant glioma	4.54e-05	9.6e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CG—malignant glioma	4.53e-05	9.58e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP2C18—malignant glioma	4.52e-05	9.57e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—malignant glioma	4.52e-05	9.56e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—malignant glioma	4.52e-05	9.56e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SPHK1—malignant glioma	4.51e-05	9.53e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CAT—malignant glioma	4.45e-05	9.42e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CB—malignant glioma	4.44e-05	9.39e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2C18—malignant glioma	4.41e-05	9.34e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ASMT—malignant glioma	4.4e-05	9.31e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—malignant glioma	4.4e-05	9.31e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—BAD—malignant glioma	4.38e-05	9.26e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PPARG—malignant glioma	4.37e-05	9.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—IDH1—malignant glioma	4.35e-05	9.2e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT2—malignant glioma	4.35e-05	9.2e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOTCH1—malignant glioma	4.33e-05	9.17e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CAV1—malignant glioma	4.33e-05	9.16e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.33e-05	9.15e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	4.31e-05	9.11e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.27e-05	9.02e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CD80—malignant glioma	4.25e-05	8.98e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.24e-05	8.97e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—APC—malignant glioma	4.24e-05	8.96e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SPHK1—malignant glioma	4.21e-05	8.9e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NCOR1—malignant glioma	4.21e-05	8.9e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGF—malignant glioma	4.19e-05	8.86e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CD—malignant glioma	4.18e-05	8.84e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.18e-05	8.83e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTPN11—malignant glioma	4.16e-05	8.81e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CD—malignant glioma	4.15e-05	8.79e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BCAN—malignant glioma	4.14e-05	8.76e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.14e-05	8.75e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2C18—malignant glioma	4.12e-05	8.72e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.1e-05	8.68e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTT1—malignant glioma	4.08e-05	8.62e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—BRAF—malignant glioma	3.98e-05	8.43e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CD—malignant glioma	3.98e-05	8.42e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—malignant glioma	3.96e-05	8.37e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CG—malignant glioma	3.94e-05	8.34e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CAV1—malignant glioma	3.9e-05	8.24e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.89e-05	8.23e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.89e-05	8.22e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT2—malignant glioma	3.88e-05	8.2e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—malignant glioma	3.84e-05	8.12e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS1—malignant glioma	3.82e-05	8.08e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—malignant glioma	3.81e-05	8.05e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.8e-05	8.05e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.75e-05	7.93e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—RAF1—malignant glioma	3.73e-05	7.89e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CD—malignant glioma	3.73e-05	7.88e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.72e-05	7.87e-05	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—malignant glioma	3.69e-05	7.81e-05	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—malignant glioma	3.69e-05	7.81e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTT1—malignant glioma	3.66e-05	7.74e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CB—malignant glioma	3.64e-05	7.7e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CB—malignant glioma	3.62e-05	7.66e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—malignant glioma	3.59e-05	7.59e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTT1—malignant glioma	3.57e-05	7.55e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGF2—malignant glioma	3.57e-05	7.55e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—BCHE—malignant glioma	3.55e-05	7.51e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—malignant glioma	3.55e-05	7.51e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.54e-05	7.49e-05	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	3.52e-05	7.44e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC5A5—malignant glioma	3.51e-05	7.42e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CB—malignant glioma	3.47e-05	7.34e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CD—malignant glioma	3.47e-05	7.33e-05	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.47e-05	7.33e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—malignant glioma	3.44e-05	7.27e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CAV1—malignant glioma	3.43e-05	7.25e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS1—malignant glioma	3.43e-05	7.25e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—malignant glioma	3.43e-05	7.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.42e-05	7.23e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.42e-05	7.22e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS1—malignant glioma	3.35e-05	7.08e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IL2—malignant glioma	3.35e-05	7.08e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MDM2—malignant glioma	3.34e-05	7.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—IDH2—malignant glioma	3.34e-05	7.06e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTT1—malignant glioma	3.34e-05	7.05e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—RAF1—malignant glioma	3.33e-05	7.04e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.32e-05	7.01e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—malignant glioma	3.29e-05	6.96e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.29e-05	6.95e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CB—malignant glioma	3.25e-05	6.87e-05	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	3.23e-05	6.83e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—malignant glioma	3.22e-05	6.81e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—BCHE—malignant glioma	3.19e-05	6.74e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC5A5—malignant glioma	3.15e-05	6.66e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.14e-05	6.64e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—malignant glioma	3.13e-05	6.62e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS1—malignant glioma	3.13e-05	6.61e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—malignant glioma	3.12e-05	6.61e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CD—malignant glioma	3.12e-05	6.6e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.11e-05	6.59e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—BCHE—malignant glioma	3.11e-05	6.58e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A5—malignant glioma	3.07e-05	6.5e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—malignant glioma	3.02e-05	6.39e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—malignant glioma	3.01e-05	6.38e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—malignant glioma	3e-05	6.34e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—malignant glioma	3e-05	6.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.98e-05	6.3e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.95e-05	6.24e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—BCHE—malignant glioma	2.91e-05	6.15e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.87e-05	6.07e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—IDH1—malignant glioma	2.87e-05	6.07e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.87e-05	6.06e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—malignant glioma	2.84e-05	6.01e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.83e-05	5.99e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—malignant glioma	2.82e-05	5.97e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—malignant glioma	2.81e-05	5.94e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—malignant glioma	2.79e-05	5.91e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SPHK1—malignant glioma	2.78e-05	5.87e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAT—malignant glioma	2.75e-05	5.81e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—malignant glioma	2.75e-05	5.81e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.72e-05	5.75e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—malignant glioma	2.72e-05	5.75e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.71e-05	5.74e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—malignant glioma	2.71e-05	5.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—malignant glioma	2.7e-05	5.7e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.69e-05	5.69e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—malignant glioma	2.61e-05	5.52e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NCOR1—malignant glioma	2.6e-05	5.49e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.57e-05	5.44e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—malignant glioma	2.54e-05	5.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—malignant glioma	2.51e-05	5.31e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—malignant glioma	2.47e-05	5.23e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAT—malignant glioma	2.47e-05	5.22e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—malignant glioma	2.42e-05	5.11e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAT—malignant glioma	2.41e-05	5.09e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—malignant glioma	2.39e-05	5.06e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—malignant glioma	2.37e-05	5.02e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—malignant glioma	2.35e-05	4.97e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.35e-05	4.96e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—malignant glioma	2.33e-05	4.93e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NCOR1—malignant glioma	2.33e-05	4.93e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—malignant glioma	2.31e-05	4.89e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—malignant glioma	2.28e-05	4.82e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—malignant glioma	2.28e-05	4.82e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NCOR1—malignant glioma	2.27e-05	4.81e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAT—malignant glioma	2.25e-05	4.76e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—malignant glioma	2.22e-05	4.7e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—malignant glioma	2.21e-05	4.68e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—malignant glioma	2.21e-05	4.67e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—malignant glioma	2.2e-05	4.65e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—malignant glioma	2.16e-05	4.56e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—malignant glioma	2.15e-05	4.54e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOR1—malignant glioma	2.12e-05	4.49e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—malignant glioma	2.12e-05	4.48e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAV1—malignant glioma	2.12e-05	4.48e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—malignant glioma	2.07e-05	4.37e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS1—malignant glioma	2.06e-05	4.36e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.02e-05	4.28e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—malignant glioma	1.98e-05	4.19e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—malignant glioma	1.93e-05	4.08e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—BCHE—malignant glioma	1.92e-05	4.05e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAV1—malignant glioma	1.9e-05	4.02e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.89e-05	4e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—malignant glioma	1.86e-05	3.93e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAV1—malignant glioma	1.85e-05	3.92e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—malignant glioma	1.84e-05	3.9e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.81e-05	3.84e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—malignant glioma	1.81e-05	3.84e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—malignant glioma	1.8e-05	3.81e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAV1—malignant glioma	1.73e-05	3.66e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.73e-05	3.66e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—malignant glioma	1.73e-05	3.66e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—malignant glioma	1.69e-05	3.58e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—malignant glioma	1.69e-05	3.57e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—malignant glioma	1.67e-05	3.53e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—malignant glioma	1.66e-05	3.51e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.65e-05	3.5e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—malignant glioma	1.63e-05	3.45e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—malignant glioma	1.62e-05	3.42e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.58e-05	3.34e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—malignant glioma	1.52e-05	3.23e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—malignant glioma	1.52e-05	3.22e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.52e-05	3.22e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—malignant glioma	1.51e-05	3.18e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—malignant glioma	1.48e-05	3.14e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAT—malignant glioma	1.48e-05	3.14e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—malignant glioma	1.48e-05	3.12e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—malignant glioma	1.46e-05	3.1e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—malignant glioma	1.46e-05	3.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOR1—malignant glioma	1.4e-05	2.96e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.39e-05	2.93e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—malignant glioma	1.35e-05	2.86e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.33e-05	2.8e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—malignant glioma	1.31e-05	2.78e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—malignant glioma	1.29e-05	2.74e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—malignant glioma	1.28e-05	2.71e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—malignant glioma	1.28e-05	2.7e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.21e-05	2.56e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—malignant glioma	1.2e-05	2.53e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—malignant glioma	1.19e-05	2.52e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—malignant glioma	1.15e-05	2.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAV1—malignant glioma	1.14e-05	2.42e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—malignant glioma	1.12e-05	2.36e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—malignant glioma	1.04e-05	2.21e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.04e-05	2.2e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—malignant glioma	1e-05	2.12e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.15e-06	1.93e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—malignant glioma	9e-06	1.9e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—malignant glioma	8.08e-06	1.71e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.97e-06	1.69e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—malignant glioma	7.9e-06	1.67e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—malignant glioma	7.89e-06	1.67e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—malignant glioma	7.37e-06	1.56e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—malignant glioma	7.35e-06	1.56e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—malignant glioma	6.89e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—malignant glioma	6.6e-06	1.4e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—malignant glioma	6.44e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—malignant glioma	6.02e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.86e-06	1.03e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—malignant glioma	3.97e-06	8.4e-06	CbGpPWpGaD
